To include your compound in the COVID-19 Resource Center, submit it here.

VY-AADC01: Interim Phase Ib data

Interim data from 10 patients with advanced PD in cohorts 1 and 2 of an open-label, dose-escalation, U.S. Phase Ib

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE